Merck Research Laboratories (MRLs) , Merck & Co., Inc. , Kenilworth , New Jersey 07033 , United States.
School of Pharmacy , University of Wisconsin-Madison , Madison , Wisconsin 53705 , United States.
Mol Pharm. 2019 Jun 3;16(6):2579-2589. doi: 10.1021/acs.molpharmaceut.9b00174. Epub 2019 May 9.
Molecular interactions between the active pharmaceutical ingredient and polymer have potentially substantial impacts on the physical stability of amorphous solid dispersions (ASDs), presumably by manipulating molecular mobility and miscibility. However, structural details for understanding the nature of the molecular contacts and mechanistic roles in various physicochemical and thermodynamic events often remain unclear. This study provides a spectroscopic characterization of posaconazole (POSA) formulations, a second-generation triazole antifungal drug (Noxafil, Merck & Co., Inc., Kenilworth, NJ, USA), at molecular resolution. One- and two-dimensional (2D) solid-state NMR (ssNMR) techniques including spectral editing, heteronuclear H-C, F-C, N-C, and F-H polarization transfer, and spin correlation and ultrafast magic angle spinning, together with the isotopic labeling strategy, were utilized to uncover molecular details in POSA ASDs in a site-specific manner. Active groups in triazole and difluorophenyl rings exhibited rich but distinct categories of interactions with two polymers, hypromellose acetate succinate and hypromellose phthalate, including intermolecular O-H···O═C and O-H···F-C hydrogen bonding, π-π aromatic packing, and electrostatic interaction. Interestingly, the chlorine-to-fluorine substituent in POSA, one of the major structural differences from itraconazole that could facilitate binding to the biological target, offers an additional contact with the polymer. These findings exhibit 2D ssNMR as a sensitive technique for probing sub-nanometer structures of pharmaceutical materials and provide a structural basis for optimizing the type and strength of drug-polymer interactions in the design of amorphous formulations.
药物活性成分与聚合物之间的分子相互作用可能会对无定形固体分散体 (ASD) 的物理稳定性产生重大影响,这可能是通过改变分子迁移率和混溶性来实现的。然而,对于理解分子接触的本质以及在各种物理化学和热力学事件中的作用机制的结构细节,通常仍不清楚。本研究提供了一种对泊沙康唑(POSA)制剂的光谱特征分析,泊沙康唑是第二代三唑类抗真菌药物(诺沙康唑,默克公司,新泽西州肯尼沃斯),具有分子分辨率。一维和二维(2D)固态 NMR(ssNMR)技术,包括谱编辑、异核 H-C、F-C、N-C 和 F-H 极化转移、自旋相关和超快速魔角旋转,以及同位素标记策略,用于以特定于位置的方式揭示 POSA ASD 中的分子细节。三唑和二氟苯基环中的活性基团与两种聚合物(醋酸羟丙甲纤维素琥珀酸酯和羟丙甲纤维素邻苯二甲酸酯)表现出丰富但不同类别的相互作用,包括分子间的 O-H···O═C 和 O-H···F-C 氢键、π-π 芳香族堆积和静电相互作用。有趣的是,POSA 中的氯到氟取代基是其与伊曲康唑的主要结构差异之一,有助于与生物靶标结合,它与聚合物之间还存在额外的接触。这些发现表明 2D ssNMR 是一种灵敏的技术,可用于探测药物材料的亚纳米结构,并为优化无定形制剂设计中药物-聚合物相互作用的类型和强度提供结构基础。